Our Board of Directors

Russell G. Greig

Chairman of the Board

Russell G. Greig

Russell built a substantial career at GlaxoSmithKline for three decades, most recently as President of SR One, GlaxoSmithKline’s corporate venture group. Over the last decade, Dr. Greig has served as Chairman and board member for a range of innovative biopharmaceutical companies in the US and in Europe including overseeing a number of successful exits.

Kenneth Chien

Co-founder of Moderna

Kenneth Chien

Professor Kenneth Chien is a self-investor to eTheRNA and has been an Advisor to EQT since 2020. Kenneth is a Co-Founder of Moderna Therapeutics, and has served as a senior consultant and advisory board member to several biotechnology and large pharmas, including Genentech, Roche, GSK, Wyeth, and Pfizer.

Marijn Dekkers

Representing Novalis LifeSciences

Marijn Dekkers

Marijn is founder and chairman of Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry that he founded in 2017.Dr. He served as CEO of Bayer AG in Germany and CEO of Thermo Fisher Scientific in USA. He started his career in 1985 as a research scientist at General Electric’s Corporate R&D Center in New York.

Bernard Sagaert

eTheRNA Interim CEO

Bernard Sagaert

Bernard Sagaert is an Industrial Pharmacist with extensive operational experience in the pharmaceutical and life sciences industry. He has expertise in pharmaceutical authorizations, inspections and manufacturing and has an extensive operational background, both in companies as as consultant. He was a former QA & Supply Chain Director at Mylan in Belgium, and VP QA EMEAA at Sterigenics, a Sotera company.

John de Koning

Representing EQT Life Sciences

John de Koning

John is a Partner at EQT Life Sciences, formerly LSP. He currently serves on the boards of eTheRNA, ONWARD Medical (Euronext: ONWD), Aelin Therapeutics, VarmX, Visus Therapeutics and Xilis. He also served on the boards of other companies, such as argenx (NASDAQ: ARGX), Merus (NASDAQ: MRUS), BMEYE (acquired by Edwards Lifesciences) and Prosensa (acquired by BioMarin).

Kenneth Wils

Kenneth Wils

Kenneth is an all-round finance and venture capital professional with a passion for life sciences and healthcare. In 2007, he joined PMV, where he was primarily active as seed and early stage venture capital provider to innovative start-ups, with a focus on life sciences and healthcare. He also served as board member in several successful technology start-ups and funds.